mhurhangee/patent-ind-claim-en huggingface dataset:
Corrugated cardboard plant for producing corrugated cardboard, comprising a) at least one device for producing a respective corrugated cardboard web laminated on one side from a respective cover web and a respective material web; b) a lamination web dispensing device for dispensing a lamination web ; c) a lamination web printing assembly , disposed downstream of the lamination web dispensing device , for imprinting the lamination web ; and d) a device , disposed downstream of the lamination web printing assembly , for producing a corrugated cardboard web laminated on two sides from the at least one corrugated cardboard web laminated on one side and the lamination web , e) wherein the lamination web printing assembly is disposed below a bridge for guiding the at least one corrugated cardboard web laminated on one side in a direction towards the device for producing a corrugated cardboard web laminated on two sides, characterized in that f) the bridge comprises at least one shield assembly for reducing a drying-up of the at least one corrugated cardboard web laminated on one side that is guided in the bridge . a) at least one device for producing a respective corrugated cardboard web laminated on one side from a respective cover web and a respective material web; b) a lamination web dispensing device for dispensing a lamination web ; c) a lamination web printing assembly , disposed downstream of the lamination web dispensing device , for imprinting the lamination web ; and d) a device , disposed downstream of the lamination web printing assembly , for producing a corrugated cardboard web laminated on two sides from the at least one corrugated cardboard web laminated on one side and the lamination web , e) wherein the lamination web printing assembly is disposed below a bridge for guiding the at least one corrugated cardboard web laminated on one side in a direction towards the device for producing a corrugated cardboard web laminated on two sides, characterized in that f) the bridge comprises at least one shield assembly for reducing a drying-up of the at least one corrugated cardboard web laminated on one side that is guided in the bridge .
A chemically defined medium for 3D tumorsphere culture, characterized in that it comprises the trace elements, - aluminum (Al), in a concentration in the range of 1.5 nM to 15 nM; - barium (Ba), in a concentration in the range of 1.5 nM to 15 nM; - bromine (Br), in a concentration in the range of 0.4 nM to 4 nM; - cadmium (Cd), in a concentration in the range of 4 nM to 40 nM; - cobalt (Co), in a concentration in the range of 1 nM to 10 nM; - chromium (Cr), in a concentration in the range of 0.5 nM to 5 nM; - germanium (Ge), in a concentration in the range of 2 nM to 20 nM; - iodine (I), in a concentration in the range of 0.25 nM to 2.5 nM; - fluorine (F), in a concentration in the range of 12 nM to 120 nM; - nickel (Ni), in a concentration in the range of 0.2 nM to 2 nM; - manganese (Mn), in a concentration in the range of 0.1 nM to 1 nM; - molybdenium (Mo), in a concentration in the range of 0.7 nM to 7 nM; - rubidium (Rb), in a concentration in the range of 4 nM to 40 nM; - selenium (Se) in a concentration in the range of 40 nM to 400 nM; - silver (Ag), in a concentration in the range of 0.3 nM to 3 nM - silicon (Si), in a concentration in the range of 130 nM to 1.3 μM - tin (Sn), in a concentration in the range of 0.1 nM to 1 nM - vanadium (V), in a concentration in the range of 2 nM to 22 nM; and - zirconium (Zr), in a concentration in the range of 3.5 nM to 35 nM. - aluminum (Al), in a concentration in the range of 1.5 nM to 15 nM; - barium (Ba), in a concentration in the range of 1.5 nM to 15 nM; - bromine (Br), in a concentration in the range of 0.4 nM to 4 nM; - cadmium (Cd), in a concentration in the range of 4 nM to 40 nM; - cobalt (Co), in a concentration in the range of 1 nM to 10 nM; - chromium (Cr), in a concentration in the range of 0.5 nM to 5 nM; - germanium (Ge), in a concentration in the range of 2 nM to 20 nM; - iodine (I), in a concentration in the range of 0.25 nM to 2.5 nM; - fluorine (F), in a concentration in the range of 12 nM to 120 nM; - nickel (Ni), in a concentration in the range of 0.2 nM to 2 nM; - manganese (Mn), in a concentration in the range of 0.1 nM to 1 nM; - molybdenium (Mo), in a concentration in the range of 0.7 nM to 7 nM; - rubidium (Rb), in a concentration in the range of 4 nM to 40 nM; - selenium (Se) in a concentration in the range of 40 nM to 400 nM; - silver (Ag), in a concentration in the range of 0.3 nM to 3 nM - silicon (Si), in a concentration in the range of 130 nM to 1.3 μM - tin (Sn), in a concentration in the range of 0.1 nM to 1 nM - vanadium (V), in a concentration in the range of 2 nM to 22 nM; and - zirconium (Zr), in a concentration in the range of 3.5 nM to 35 nM.
A communication apparatus (10#0), comprising: a processing unit configured to generate a downlink frame indicating designation information designating a transmission process for multiplexing differing for each of a plurality of other communication apparatuses (10#1 - 10#4); and a communication unit configured to frequency-division multiplex the downlink frame generated by the processing unit and transmit the frequency-division multiplexed downlink frame to the plurality of other communication apparatuses, wherein the designation information includes information indicating different frequencies used for the frequency-division multiplexing of the downlink frame and to be used by the plurality of other communication apparatuses for transmitting an acknowledgement, ACK, response to the frequency-division multiplexed downlink frame. a processing unit configured to generate a downlink frame indicating designation information designating a transmission process for multiplexing differing for each of a plurality of other communication apparatuses (10#1 - 10#4); and a communication unit configured to frequency-division multiplex the downlink frame generated by the processing unit and transmit the frequency-division multiplexed downlink frame to the plurality of other communication apparatuses, wherein the designation information includes information indicating different frequencies used for the frequency-division multiplexing of the downlink frame and to be used by the plurality of other communication apparatuses for transmitting an acknowledgement, ACK, response to the frequency-division multiplexed downlink frame.
Screening method for diagnosis of haematological neoplasia, comprising the steps of: - performing a first test step to check for potential haematological neoplasia, wherein the first test step is performed partially or fully automated, wherein as part of the first test step at least a first haematogram is created with a blood sample in the liquid phase and it is checked based on a first set of filter rules whether the first haematogram deviates from a desired state specified according to the first set of filter rules, and wherein the first set of filter rules comprises at least two filter rules, wherein the at least first haematogram comprises a haemoglobin value and a platelets value, and wherein a filter rule of the first set of filter rules of the first test step is based on the haemoglobin value and the platelets value, and - performing a second test step to check for potential haematological neoplasia if the first test step indicates that there is potential haematological neoplasia, wherein the second test step is partially or completely automated, wherein as part of the second test step a morphological analysis result of a solid phase of the blood sample is determined and it is checked based on a second set of filter rules whether the morphological analysis result of the second test step deviates from a desired state specified according to the second set of filter rules, and wherein the second set of filter rules comprises at least two filter rules. - performing a first test step to check for potential haematological neoplasia, wherein the first test step is performed partially or fully automated, wherein as part of the first test step at least a first haematogram is created with a blood sample in the liquid phase and it is checked based on a first set of filter rules whether the first haematogram deviates from a desired state specified according to the first set of filter rules, and wherein the first set of filter rules comprises at least two filter rules, wherein the at least first haematogram comprises a haemoglobin value and a platelets value, and wherein a filter rule of the first set of filter rules of the first test step is based on the haemoglobin value and the platelets value, and - performing a second test step to check for potential haematological neoplasia if the first test step indicates that there is potential haematological neoplasia, wherein the second test step is partially or completely automated, wherein as part of the second test step a morphological analysis result of a solid phase of the blood sample is determined and it is checked based on a second set of filter rules whether the morphological analysis result of the second test step deviates from a desired state specified according to the second set of filter rules, and wherein the second set of filter rules comprises at least two filter rules.
An alignment device (20; 30) for aligning femoral and tibial bones at a knee joint , the device comprising: a femoral portion (22; 32) to be coupled to the femoral bone , and comprising either an intramedullary rod sensor or a flat device comprising an extramedullary sensor ; and a tibial portion to be mounted on the tibial bone , and comprising a sensor rod mounted on two clamps and including a sensor on the tibial portion to enable determination of femoral and tibial axis in relation to each other. a femoral portion (22; 32) to be coupled to the femoral bone , and comprising either an intramedullary rod sensor or a flat device comprising an extramedullary sensor ; and a tibial portion to be mounted on the tibial bone , and comprising a sensor rod mounted on two clamps and including a sensor on the tibial portion to enable determination of femoral and tibial axis in relation to each other.
Method for establishing a control channel between a control unit for controlling at least one building-internal electrical component connected to a building-internal access portal and the building-internal access portal , wherein the communication between the control unit and the building-internal access portal for the purpose of controlling the at least one building-internal electrical component is effected, on a case-by-case basis, either with the involvement of a building-external network or, to shorten the latency, only via a building-internal network by establishing a local control channel , involving: authenticating the control unit to a building-external authentication server via a building-external communication network; conveying a network address of the building-internal access portal to the control unit by means of the building-external authentication server in the event of successful authentication of the control unit to the building-external authentication server via the building-external communication network ; conveying an access authorization to access the building-internal access portal to the control unit by means of the building-external authentication server via the building-external communication network in the event of successful authentication of the control unit to the building-external authentication server via the building external communication network ; and establishing a control channel between the control unit and the building-internal access portal in response to reception of the network address of the building-internal access portal and the access authorization. authenticating the control unit to a building-external authentication server via a building-external communication network; conveying a network address of the building-internal access portal to the control unit by means of the building-external authentication server in the event of successful authentication of the control unit to the building-external authentication server via the building-external communication network ; conveying an access authorization to access the building-internal access portal to the control unit by means of the building-external authentication server via the building-external communication network in the event of successful authentication of the control unit to the building-external authentication server via the building external communication network ; and establishing a control channel between the control unit and the building-internal access portal in response to reception of the network address of the building-internal access portal and the access authorization.
A method comprising: forming a plurality of die in a source wafer by selectively etching a lift-off layer formed in the source wafer between a substrate layer and a layer comprising the die, wherein the source wafer comprises a top layer of tether material from which the die are suspended, and which includes openings to expose the layer comprising the die to an etchant; transferring, by micro-transfer printing, the plurality of die from the source wafer onto an intermediate handle wafer comprising a substrate coated with an adhesive layer to create an intermediate handle wafer structure including the die, wherein transferring the plurality of die comprises picking the die from the source wafer and placing the die onto the adhesive layer of the intermediate handle wafer using a micro-transfer printing stamp brought in contact with the tether material at locations of the die; bonding the intermediate handle wafer structure die-down onto a target wafer , and removing the substrate and adhesive layer of the intermediate handle wafer, leaving the die bonded to the target wafer. forming a plurality of die in a source wafer by selectively etching a lift-off layer formed in the source wafer between a substrate layer and a layer comprising the die, wherein the source wafer comprises a top layer of tether material from which the die are suspended, and which includes openings to expose the layer comprising the die to an etchant; transferring, by micro-transfer printing, the plurality of die from the source wafer onto an intermediate handle wafer comprising a substrate coated with an adhesive layer to create an intermediate handle wafer structure including the die, wherein transferring the plurality of die comprises picking the die from the source wafer and placing the die onto the adhesive layer of the intermediate handle wafer using a micro-transfer printing stamp brought in contact with the tether material at locations of the die; bonding the intermediate handle wafer structure die-down onto a target wafer , and removing the substrate and adhesive layer of the intermediate handle wafer, leaving the die bonded to the target wafer.
A tray table device, in particular a passenger seat tray table device, with at least one table unit (10a; 10b; 10c; 10d), and with at least one cup holder unit (12a; 12b; 12c; 12d) which is provided in at least one position of use to at least partly hold at least one drinking vessel , wherein the cup holder unit (12a; 12b; 12c; 12d) is movably mounted to the table unit (10a; 10b; 10c; 10d), wherein in the position of use the cup holder unit (12a; 12c; 12d) and the table unit (10a; 10c; 10d) implement at least one holding zone (16a; 16c; 16d) for the drinking vessel , which features a holding recess (36a; 36c; 36d), wherein the cup holder unit (12a; 12c; 12d) features a first recess (38a; 38c; 38d) and the table unit (10a; 10c; 10d) features a second recess (40a; 40c; 40d), which in a position of use together implement the holding recess (36a; 36c; 36d), wherein in the position of use at least a part of an outer contour (68a; 68c; 68d) of the table unit (10a; 10c; 10d), which is an outer contour of the second recess (40a; 40c; 40d), implements at least a part of the holding zone (16a; 16c; 16d).
Apparatus for optical imaging of Cerenkov luminescence from an object subsequent to the object receiving a dose of a radiopharmaceutical, the apparatus comprising: a light tight enclosure within which the sample can be received at a sample location; a first imaging means for capturing a first image of the sample whilst the sample is illuminated, the first imaging means having a first dynamic range; a second imaging means outside of the enclosure, the second imaging means configured for Cerenkov luminescence imaging for capturing a second image of the sample whilst the sample is not illuminated, the second imaging means having a second dynamic range; and one or more optical elements, wherein light paths feeding the first and second imaging means pass through the optical elements such that the first and second imaging means both image the same region of the sample. a light tight enclosure within which the sample can be received at a sample location; a first imaging means for capturing a first image of the sample whilst the sample is illuminated, the first imaging means having a first dynamic range; a second imaging means outside of the enclosure, the second imaging means configured for Cerenkov luminescence imaging for capturing a second image of the sample whilst the sample is not illuminated, the second imaging means having a second dynamic range; and one or more optical elements, wherein light paths feeding the first and second imaging means pass through the optical elements such that the first and second imaging means both image the same region of the sample.
A peritoneal dialysis system comprising: a bellows ; a common inlet/outlet fluid receptacle in fluid communication with the bellows; a plurality of fluid lines in fluid communication with the common inlet/outlet receptacle; a linear actuator positioned and arranged to expand and compress the bellows; a plurality of valves positioned and arranged to allow or occlude flow through the plurality of fluid lines to or from the bellows; and a control unit configured to control the linear actuator and the plurality of valves . a bellows ; a common inlet/outlet fluid receptacle in fluid communication with the bellows; a plurality of fluid lines in fluid communication with the common inlet/outlet receptacle; a linear actuator positioned and arranged to expand and compress the bellows; a plurality of valves positioned and arranged to allow or occlude flow through the plurality of fluid lines to or from the bellows; and a control unit configured to control the linear actuator and the plurality of valves .
A liquid composition comprising a liquid medium, a sulfonic acid group-containing fluorocarbon polymer, and a hardly soluble cerium compound, of which the solubility in water at 25 °C is at most 0.1g to 100g of water, wherein the ion exchange capacity of the sulfonic acid group-containing fluorocarbon polymer is from 1.36 to 2.50 meq/g dry resin, the average particle size of the hardly soluble cerium compound is from 1 nm to 3,000 nm, and the ratio of the total number of moles of cerium atoms in the hardly soluble cerium compound to the total number of moles of sulfonic acid groups contained in the sulfonic acid group-containing fluorocarbon polymer is from 0.001 to 0.3. a liquid medium, a sulfonic acid group-containing fluorocarbon polymer, and a hardly soluble cerium compound, of which the solubility in water at 25 °C is at most 0.1g to 100g of water, wherein the ion exchange capacity of the sulfonic acid group-containing fluorocarbon polymer is from 1.36 to 2.50 meq/g dry resin, the average particle size of the hardly soluble cerium compound is from 1 nm to 3,000 nm, and the ratio of the total number of moles of cerium atoms in the hardly soluble cerium compound to the total number of moles of sulfonic acid groups contained in the sulfonic acid group-containing fluorocarbon polymer is from 0.001 to 0.3.
A hyper heat accelerator for a heating device, comprising a material selected from the group consisting of SnF 2 , SnF 4 , tin nickel fluoride (SnNiF), tin chromium fluoride (SnCrF), tin zinc fluoride (SnZnF), zinc nickel fluoride (ZnNiF) and combinations thereof, characterized in that the hyper heat accelerator is hyper heat accelerator dots having a spherical shape and a diameter of 50 to 100 nm.
A magnetic sensor module comprising a substrate ; a magnetic sensor ; and a second joining material , the substrate having a wire on a principal surface thereof, the magnetic sensor having an electrode pad formed on one surface thereof, the magnetic sensor being mounted on the principal surface of the substrate using a first joining material so that another surface thereof orthogonal to the one surface opposes the principal surface of the substrate , the second joining material electrically connecting the wire and the electrode pad to each other, the magnetic sensor has a joining material accommodation area that is situated between the electrode pad and the another surface and that is capable of being filled with the first joining material , the joining material accommodation area is formed so as to have a grooved structure provided at an end portion near the wire , characterized in that die-bond resin is used as the first joining material , and the die-bond resin fills both the grooved structure of the magnetic sensor and a side of the magnetic sensor which is an opposite side to the wire .
Method for operating a generator for an internal combustion engine of a vehicle having a starting operating condition and a start-stop operating condition, wherein a generator torque is limited in the starting operating condition, comprising: detecting an operating condition of the vehicle; and deactivating a limitation of the generator torque, characterised in that the generator torque limitation is deactivated if the detected operating condition corresponds to the start/stop operating condition. detecting an operating condition of the vehicle; and deactivating a limitation of the generator torque, characterised in that the generator torque limitation is deactivated if the detected operating condition corresponds to the start/stop operating condition.
A method for identifying a cancer subject who will clinically respond to treatment with cyclophosphamide or an analogue or derivative thereof, the method comprising detecting expression of CCR4 on Teff cells obtained from a subject who has previously been administered at least one dose or cycle of cyclophosphamide, or an analogue, or derivative thereof, wherein upregulation of CCR4 expression on the Teff cells indicates that the subject will clinically respond to treatment.
Method for surface processing at least a portion of a component of zirconium or hafnium alloy for light water nuclear reactor, characterised in that it comprises at least one operation of nanostructuring a surface layer of the alloy so as to confer on the alloy over a thickness of at least 5 μm a grain size which is less than or equal to 100 nm, the nanostructuring being carried out at a temperature which is less than or equal to that of the last thermal processing operation to which the component was previously subjected during its production, and by means of an ultrasonic peening method.